Thomas L. Churchwell

Tom Churchwell is the founder and CEO of ViMedicus, Inc. ViMedicus develops and markets patient centric care coordination solutions. He is also Managing Partner of Midwest Venture Partners and of ARCH Development Partners early stage venture partnerships. Previously, he was President and CEO of ARCH Development Corporation, a subsidiary of the University of Chicago, which commercialized technology from the University and Argonne National Laboratory. Prior to that, he was President and CEO of Calgene Fresh, Inc., a 1992 start-up company which produced and marketed the MacGregor’s FLAVR SAVR tomato, the world’s first biotech food product. Prior to joining Calgene Fresh, Mr. Churchwell was Vice President of ARCH Development Corporation Development. Before starting Calgene Fresh, Mr. Churchwell held several senior management positions at the NutraSweet Company and legal positions at G.D. Searle & Co., American Hospital Supply Corporation and The Coca-Cola Export Corporation. He holds a BA degree from DePauw Universityand JD degree from Northwestern University School of Law. He also is a Graduate of the Advanced Management Program at Harvard Graduate School of Business Administration.